Yamasaki, Toshinari <br/><br/>
Exploring a glycolytic inhibitor for the treatment of an FH-deficient type-2 papillary RCC.  [electronic resource] 

 -  Nature reviews. Urology  Mar 2011 
 - 165-71 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1759-4820 
<br/><br/><label>Standard No.: </label>10.1038/nrurol.2010.234  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Carcinoma, Papillary--drug therapy<br/>Carcinoma, Renal Cell--drug therapy<br/>Fatal Outcome<br/>Female<br/>Fumarate Hydratase--deficiency<br/>Glycolysis--drug effects<br/>Humans<br/>Kidney Neoplasms--drug therapy<br/>Mechanistic Target of Rapamycin Complex 1<br/>Multiprotein Complexes<br/>Proteins--antagonists & inhibitors<br/>TOR Serine-Threonine Kinases<br/>Treatment Outcome<br/>Young Adult